What BBI Group does

BBI Group, operating commercially as BBI Solutions, is a UK-headquartered (Llanishen) manufacturer of biological reagents serving the in vitro diagnostics (IVD) and life sciences industries. Founded around 1955 and operating for approximately 70 years, the company is privately held with 501-1,000 employees and a global commercial footprint organized around regional teams serving local-language markets. Its reagents — enzymes, monoclonal and polyclonal antibodies, antigens, gold colloids, and gold conjugates — form the core detection components of IVD tests, lateral flow assays, ELISA kits, and related immunoassays, with stated end-impact of powering more than 5 billion annual glucose strip tests and over 400 million lateral flow tests worldwide.

Core technology centers on proprietary gold conjugation chemistry delivering ultra-uniform nanoparticles (coefficient of variation ≤8%) for consistent assay performance, plus a vertically integrated manufacturing stack. Capabilities span antibody development including antigen mapping and high-affinity hybridoma generation; antibody production scaling to 5g using roller-bottle or hollow-fibre bioreactors; protein customization with purification in batches up to 5,000L; and lateral flow contract manufacturing inside ISO 13485-certified cleanrooms using automated striping, laminating, cutting, and assembly lines. The supporting reagent portfolio extends to cell culture reagents, human serum and control materials, stabilizers, blockers, substrates, immuno-affinity columns, polystreptavidin, and ELISA kits.

BBI generates revenue through two primary streams: catalog reagent sales (unit-priced SKUs via the shop.bbisolutions.com e-commerce storefront) and custom contract manufacturing services (project-priced engagements for antibody development, gold conjugation, protein customization, and lateral flow contract manufacture). The go-to-market is enterprise sales-led: regional field teams engage IVD and life sciences manufacturers directly, supported by customer service and on-staff scientists for technical troubleshooting. The customer base is horizontal across IVD manufacturers and life sciences companies serving clinical areas including allergy, autoimmune and inflammation, cardiac and vascular, tumour markers, diabetes and renal, hormones, infectious disease, and plasma proteins. Pricing is not publicly disclosed and is quote-based for both catalog and custom work. Inputs contain no disclosed revenue figures, funding rounds, M&A activity, or patent portfolio, indicating organic, privately-financed growth to date.

Name

BBI Group

Legal name

BBI Solutions

Website

https://the-bbigroup.com

Company type

Private

Founded year

1955

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BBI Group (operating as BBI Solutions) is a UK-based, privately held manufacturer of biological reagents—enzymes, antibodies, antigens, gold colloids, and gold conjugates—serving in vitro diagnostics manufacturers and life sciences companies globally for approximately 70 years.

Ownership category

akta.pro rank

Product category

Diagnostic Reagents (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Diagnostic reagents
• IVD manufacturing
• Gold nanoparticles
• Lateral flow assays
• Antibody development

Headquarters

HQ city

Llanishen

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Reagent Sales: Sale of catalog reagents including enzymes, antibodies, antigens, gold colloids, conjugates, cell culture reagents, human serum, stabilizers, and substrates to IVD and life sciences manufacturers.
2. Custom Manufacturing Services: Contract manufacturing and customization services including antibody development, antibody production, gold conjugation, protein customization, and lateral flow contract manufacture. Services are tailored to customer specifications with regulatory-compliant supply.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

BBI Group (operating as BBI Solutions) manufactures and supplies biological reagents—including enzymes, antibodies, antigens, gold colloids, and gold conjugates—for in vitro diagnostics (IVD) and life sciences manufacturers. It complements its catalog of detection and binding reagents with custom manufacturing services such as antibody development, gold conjugation, protein customization, and ISO 13485-certified lateral flow contract manufacturing, scaling from pilot batches to multi-million-unit production runs.

Product overview

BBI Solutions operates as a unified reagent platform serving the in vitro diagnostics (IVD) and life sciences industries. The portfolio centers on biological reagents — enzymes, antibodies, antigens, gold colloids, and conjugates — which form the foundational detection and binding components used by IVD manufacturers to build lateral flow tests, ELISA kits, and other immunoassays. These core products are complemented by supporting reagents including cell culture products, human serum and control materials, stabilizers, blockers, substrates, immuno-affinity columns, and polystreptavidin. The company also offers contract services including antibody development and manufacturing, custom gold conjugation, protein customization, and lateral flow contract manufacture. With over 70 years of history, BBI's reagents power an estimated 5 billion+ annual glucose strip tests and 400 million+ annual lateral flow tests.

Differentiator

Problem solved

Functional benefit

Products and services

• Enzymes Biological catalysts used in diagnostic applications, including glucose oxidase used in glucose monitoring strips; supplied to IVD and life sciences manufacturers.
• Antibodies Monoclonal and polyclonal antibodies for immunoassay development and diagnostic applications, with production scaling up to 5g using roller-bottle or hollow-fibre bioreactors.
• Gold Colloid Gold nanoparticle colloids used as detection labels in lateral flow and other immunoassays, powering over 400 million annual lateral flow tests.
• Gold Conjugates Antibody-antigen or oligo conjugates linked to gold nanoparticles for lateral flow assay detection, with ultra-uniform nanoparticles (≤8% CV) and batch scaling to 24L at OD10.
• Antigens Native and recombinant antigens for diagnostic assay development across multiple clinical areas.
• Cell Culture Reagents Cell culture products and reagents for maintaining and growing cell lines used in antibody production.
• Human Serum & Control Materials Human serum and control materials used as reference standards and quality controls in diagnostic testing.
• Stabilizers, Blockers & Substrates Formulation components including stabilizers, blockers, and substrates used to optimize assay performance and shelf-life.
• Immuno-affinity Columns (IAC) Immuno-affinity columns for purification and isolation of target analytes from complex biological samples.
• Polystreptavidin Polystreptavidin products for binding biotinylated molecules in diagnostic and research applications.
• ELISA Kits Enzyme-linked immunosorbent assay kits for human diagnostic applications.
• Custom Antibody Development & Production Custom antibody development including antigen mapping, high-affinity hybridoma generation, and production scaling up to 5g using roller-bottle or hollow-fibre bioreactors. Targeted at IVD manufacturers needing tailored antibody reagents.
• Custom Gold Conjugation Custom conjugation of antibodies, antigens, or oligos to gold nanoparticles, performing 600+ custom conjugations per year with batch scaling to 24L at OD10.
• Protein Customization Gene screening, fermentation fine-tuning from pilot to production scale, and protein purification at up to 5,000L batches.
• Lateral Flow Contract Manufacturing ISO 13485-certified cleanrooms with automated lines for striping, laminating, cutting, and assembling lateral flow devices, scaling from pilot lots to multi-million-unit runs.

Quantifiable outcome

• 5 billion+ glucose strip tests powered annually by BBI enzymes
• +5 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Lateral DxcoreStrategic or Co-development PartnerBBI and Lateral Dx partnership focused on advancing lateral flow diagnostics through collaboration on reagents and manufacturing capabilities. This partnership combines BBI's reagent expertise with Lateral Dx's diagnostic development capabilities.

Scale indicators9 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• GenScript: Provides custom antibody development, recombinant proteins, and gene synthesis services to IVD and research customers — directly competing with BBI's antibody development and protein customization offerings.
• Cytodiagnostics: Specializes in gold and silver nanoparticles and custom bioconjugation services for diagnostic and research applications — directly comparable to BBI's gold colloid and custom gold conjugation product lines.
• Abcam: Specialist antibody and immunoassay reagent supplier (now part of Danaher) serving IVD and research customers. Closely comparable catalog and custom antibody business, with strong overlap in research-grade reagents.
• Bio-Rad Laboratories: Bio-Rad manufactures clinical diagnostics and life science research products, including antibodies, immunoassay reagents, and quality controls — directly overlapping with BBI's IVD reagent and custom manufacturing offering.
• Meridian Bioscience: Develops and manufactures diagnostic test components and reagents, including antigens, antibodies, and immunoassay kits — directly comparable to BBI's IVD reagent and lateral flow test component business.
• Surmodics: Supplies proprietary reagents and coatings used in diagnostic immunoassays and lateral flow devices, including particle and surface chemistry — a direct overlap with BBI's gold conjugate and lateral flow component offering.

Broad incumbents

• Cytiva (Danaher): Provides bioreactors, purification resins, and bioprocessing consumables for protein and antibody production — comparable to BBI's fermentation, purification, and bioreactor-based antibody production capabilities.
• Merck KGaA (MilliporeSigma / Sigma-Aldrich): Life science reagents giant offering enzymes, antibodies, and assay components across IVD and research customers. Directly comparable catalog and custom reagent portfolio, though as part of a much broader portfolio rather than IVD-specialized.
• Thermo Fisher Scientific: Through brands like Invitrogen and Pierce, Thermo Fisher supplies antibodies, proteins, and immunoassay reagents to IVD developers and life sciences customers — the same horizontal reagent market BBI serves, but at vastly greater scale.

Emerging players

• Bangs Laboratories: Manufacturer of polymer and silica microsphere particles used in diagnostic immunoassays and lateral flow — comparable to BBI's gold nanoparticle and conjugate reagents, though focused on a broader range of particle technologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BBI Group